Immuno-Oncology (IO) Therapies for Colorectal Cancer Liver Metastases
Surgical resection remains the primary curative treatment option for patients with colorectal liver metastases. During this course, Dr. Sofocleous will discuss the potential initiating treatment with immuno-oncology instead of tumor resection.
Oncologists, Radiation Oncologists, Hematology Oncologists, General Surgeons, General Practitioners, Obstetricians and Gynecologists, Patient Navigators, Nurse Practitioners and all other interested healthcare professionals.
- Determine when to implement ablation instead of resection, assessing the tumor and considering patient selection criteria.
- Implement evidence-based best practices for intra-arterial therapy for colon rectal cancer (CRC) liver metastases.
- Discuss future directions to optimize IO therapies for CRC liver metastases.
Constantinos T. Sofocleous, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center
New York, New York
Constantinos T. Sofocleous, M.D., Ph.D., faculty for this educational activity, has disclosed that he has received grant/research support from BTG/BSX, SIRTEX, Ethicon J&J. He is also a consultant/advisory board member with BTG/BSX, SIRTEX, Ethicon J&J, Terumo and Varian and is on the speakers’ bureau with Ethicon J&J and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Guilherme Rabinowits, M.D., conference director of this educational activity, has disclosed that he is a consultant with Sanofi and Regeneron.
Ripal Gandhi, M.D., moderator for this educational activity, has disclosed that he is a consultant with Medtronic, BD, Cordis, Trisalus Life Sciences and Sirtex Medical.
All of the relevant financial relationships listed for these individuals have been mitigated.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.